Novartis Deutschland
Leading pharmaceutical innovation and research
- B2B
About Novartis Deutschland
A leading pharmaceutical company focused on innovating medicine to enhance people's lives through scientific research and digital technologies
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Nuremberg, Bavaria, Germany
- Revenue
- $59.7M – $472MTamtam estimate
- Website
- novartis.com
Novartis Deutschland in the news
- Swiss Market Index gibt nach; Novartis-Aktien unter Druck
Novartis shares are experiencing pressure, leading to a dip in the Swiss Market Index, and the document details various composite rating methodologies used for investment analysis.
- Warum Deutschland Forschung und Versorgung gemeinsam denken muss
The article emphasizes the need for Germany to better connect medical research, investment, and healthcare to ensure innovative therapies reach patients, criticizing current policies that hinder this process.
- Novartis erhält für Rhapsido FDA-Zulassung bei weiterer Hautkrankheitsform
Novartis obtained FDA approval for Rhapsido to treat symptomatic dermographism, expanding its use for chronic hives.
Novartis Deutschland at a glance
Novartis Deutschland is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Nuremberg, Bavaria, Germany.
Novartis Deutschland has 251–1,000 employees.
Novartis Deutschland's revenue is $59.7M – $472M (Tamtam estimate).
Frequently asked questions about Novartis Deutschland
What is Novartis Deutschland's revenue?
Tamtam estimates Novartis Deutschland's annual revenue at $59.7M – $472M.
How many employees does Novartis Deutschland have?
Novartis Deutschland has 251–1,000 employees.
Where is Novartis Deutschland headquartered?
Novartis Deutschland is headquartered in Nuremberg, Bavaria, Germany.
Selling to companies like Novartis Deutschland?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies